1 

15-3785-cv(L) 

Abbott Labs. v. Adelphia Supply USA

UNITED STATES COURT OF APPEALS 

FOR THE SECOND CIRCUIT 

SUMMARY ORDER

Rulings by summary order do not have precedential effect. Citation to a summary order 

filed on or after January 1, 2007, is permitted and is governed by Federal Rule of Appellate 

Procedure 32.1 and this court’s Local Rule 32.1.1. When citing a summary order in a 

document filed with this court, a party must cite either the Federal Appendix or an 

electronic database (with the notation “summary order”). A party citing a summary order 

must serve a copy of it on any party not represented by counsel. 

 At a stated Term of the United States Court of Appeals for the Second Circuit, held at the 

Thurgood Marshall United States Courthouse, at 40 Foley Square, in the City of New York, on 

the 3rd day of November, two thousand sixteen. 

 

Present: ROBERT A. KATZMANN, 

 Chief Judge, 

 RALPH K. WINTER, 

 RICHARD C. WESLEY, 

 Circuit Judges. 

________________________________________________ 

ABBOTT LABORATORIES, ABBOTT DIABETES 

CARE, INC., ABBOTT DIABETES CARE SALES 

CORPORATION, 

 Plaintiffs-Appellees, 

 v. No. 15-3785-cv(L) 

 No. 15-3858-cv(CON) 

H&H WHOLESALE SERVICES, INC., HOWARD 

GOLDMAN, LORI GOLDMAN, MATRIX 

DISTRIBUTORS, INC., CHRISTOPHER BENEVENT, 

SETH GRUMET, 

 

 Defendants-Appellants, 

ADELPHIA SUPPLY USA, YUDAH NEUMAN, a/k/a 

LENNY NEUMAN, REUVEN SOBEL, a/k/a CHAIM 

SOBEL, MOSES NEUMAN, SHMUEL LEZELL, SAVE 

RITE MEDICAL.COM LLC, MARC KAPLAN, 

PAPOUTSANIS USA, LLC, d/b/a VIP 

INTERNATIONAL-DROGARIS, GEORGE DROGARIS, 
2 

OSD CAPITAL, INC., f/k/a FARNES ENTERPRISES 

CORPORATION, OVERSTOCKDRUGSTORE.COM 

LLC, d/b/a SIMPLEMED SUPPLY, RICK EVENSON, 

KEVIN PLUMB, BUDGET HEALTH CORPORATION, 

d/b/a BUDGET DRUGS PHARMACY, JOHN FANDETTI, 

ROBERT NEWMYER, MARIA FANDETTI, LORI BLUE, 

ANTHONY MEOLA, MARK D. HENKIN, DREAM 

CEREAL INC., d/b/a DIABETESSUPPLIES4LESS.COM, 

DOUGLAS HAUCK, BERKELY DRUGS INC., MAJID 

HAMEED, EUGENE HA, CAREWAY PHARMACY 

INC., ANATOLIY FAIN, HARRICO-GALLER DRUG 

CORPORATION, JOHN GALLAGHER, HABER JN INC., 

d/b/a THE MODERN CHEMIST, NAOMI HABER, 

JERRY HABER, NORSTRAND PHARMACY, LLC, d/b/a 

VANDERVEER PHARMACY, SARATHCHANDRA 

ADUSUMALLI, HEMAGIRI GAYAM, LEV RX CORP, 

d/b/a KIRAS PHARMACY, KIRA LEVKOUSKAYA, 

ELIYAHUS PHARMACY, INC., ILIAS MLABASATI, 

GLOBAL CARE PHARMACY, INC., D.K.Y. 

ENTERPRISES, INC., d/b/a 8TH AVENUE PHARMACY, 

KIM PING JIM, TGIS PHARMACY, INC., d/b/a 

SUNRISE FAMILY PHARMACY, SAJID JAVED, BAY 

PHARMACY INC., IRENE PIKER, B & T PHARMACY, 

INC., ANATOLY GOROKHOVSKY, LARKE DRUGS, 

INC., d/b/a 110 PHARMACY & SURGICAL, PRASAD 

VENIGALLA, LA RUCHE PHARMACY, INC., SUNIL B. 

PATEL, ESTATES PHARMACY, INC., MOHAMMED 

NURUDDIN, JOHN DOE, 1-10, NOVEX AMERICA, 

DENNIS CANTOR, TRI-STATE MEDICAL SUPPLIES 

EQUIP. CORP., ERWIN GANZFRIED, MORDECHAI 

KRITZLER, VALUE WHOLESALE, INC., DIANE 

BROWN, MEDICAL DISCOUNT SERVICES, INC., 

BRIAN MESIKA, DARRYL SCHREIBER, XPRESS 

MEDICAL SUPPLIES CORP., d/b/a PAYLESS 

DISTRIBUTORS, MOHAMMED PATEL, ZUBEDA 

MOTI, MUHAMMAD ARIF, SAPS DRUG 

WHOLESALE, INC., VILAS ASMIN, RAJESH AMIN, 

NIMESH AMIN, IXTHUS MEDICAL SUPPLY, INC., 

KARL KUNSTMAN, COMPLY USA INC., IRANY NIR, 

OFEK MESSIKA, KIMBERLY PASZKIEWICZ, 

DRUGPLACE, INC., PAUL LEIGHT, KEVIN SINGER, 

HMF DISTRIBUTING INC., WHOLESALE DIABETIC 

SUPPLIES INC., ROSS TRAGER, MATTHEW FRANK, 

PRIMED PHARMACEUTICALS LLC, VINCENT 

MONDENADO, MATTHEW ZEIGLER, NE MEDICAL 

SUPPLY USA, INC., DANIELLE WAYNE, NICK 
3 

WAYNE, TAS MEDICAL SUPPLY COMPANY, INC., 

TZVI SKLARZ, PRODUCT PERFORMANCE 

COMPANY, INC., JERROLD HERMAN, STEPHEN 

HERMAN, MED-PLUS, INC., ROGER MEZHIBOVSKY, 

DELRAY MARKETING, LLC, STEVE MICHAELS, 

DIABETIC PHARMACY SOLUTIONS, LLC, KARL 

BUCHOLZ, GLOBE WANTED, MASSALAH TRADING 

U.S.A. LTD., SAAD HADDAD, a/k/a SAM, 

HAVEMEYER PHARMACY INC., a/k/a/ SOUTH 

SECOND PHARMACY, MICHAEL BASSANELL, 

 Defendants. 

_____________________________________________ 

For Defendants-Appellants 

H&H Wholesale Service, Inc., 

Howard Goldman, and 

Lori Goldman: JOHN SHAEFFER (William Rudy, on the brief), Fox Rothschild 

LLP, Los Angeles, CA; Jason Yert, Kerr Russell and Weber, 

PLC, Detroit, MI (on the brief). 

For Defendants-Appellants 

Matrix Distributors, Inc., 

Christopher Benevent, and 

Seth Grumet: MARTIN I. SAPERSTEIN, Goodman & Saperstein, Garden City, 

NY. 

For Plaintiffs-Appellees: GEOFFREY POTTER (Aron Fischer, Timothy A. Waters, on the 

brief), Patterson Belknap Webb & Tyler LLP, New York, NY. 

 Appeal from the United States District Court for the Eastern District of New York 

(Amon, J.). 

 ON CONSIDERATION WHEREOF, IT IS HEREBY ORDERED, ADJUDGED, 

and DECREED that the judgment of the district court is AFFIRMED. 

Defendants-Appellants H&H Wholesale Services, Inc., Howard Goldman, and Lori 

Goldman (“H&H”) and Defendants-Appellants Matrix Distributors, Inc., Christopher Benevent, 

and Seth Grumet (“Matrix”) appeal from a judgment of the United States District Court for the 
4 

Eastern District of New York (Amon, J.) granting the motion of Plaintiffs-Appellees Abbott 

Laboratories, Abbott Diabetes Care, Inc., and Abbott Diabetes Sales Corporation (“Abbott”) for 

a preliminary injunction enjoining a majority of the defendants from importing, distributing, or 

otherwise using in commerce in the United States plaintiffs-appellees’ “FreeStyle” brand bloodglucose test strips intended for international sale. For substantially the reasons that the district 

court granted the motion, we AFFIRM the judgment of the district court. We assume the parties’ 

familiarity with the underlying facts, the procedural history, and the issues on appeal. 

“The district court has wide discretion in determining whether to grant a preliminary 

injunction,” and we review that decision “only for abuse of discretion.” Grand River Enter. Six 

Nations, Ltd. v. Pryor, 481 F.3d 60, 66 (2d Cir. 2007) (per curiam) (quoting Moore v. Consol. 

Edison Co. of N.Y., 409 F.3d 506, 511 (2d Cir. 2005)). “Such abuse of discretion ‘usually 

consists of clearly erroneous findings of fact or the application of an incorrect legal standard.’” 

Id. (quoting Nicholson v. Scoppetta, 344 F.3d 154, 165 (2d Cir. 2003)). 

The district court may grant a preliminary injunction if the plaintiff has shown (1) a 

likelihood of success on the merits; (2) a likelihood of “irreparable harm in the absence of 

preliminary relief”; (3) “that the balance of equities tips in [the plaintiff’s] favor”; and (4) “that 

an injunction is in the public interest.” Winter v. Nat. Res. Def. Council, Inc., 555 U.S. 7, 20 

(2008); Am. Civil Liberties Union v. Clapper, 785 F.3d 787, 825 (2d Cir. 2015). 

H&H argues that the district court abused its discretion in finding that Abbott was likely 

to succeed on the merits of its trademark infringement claims brought against H&H. Both H&H 

and Matrix argue that the district court abused its discretion in finding a likelihood of irreparable 

harm in the absence of preliminary relief. We find no abuse of discretion in the district court’s 

thorough and well-reasoned order. 
5 

We have considered all of the defendants-appellants’ arguments on this appeal and we 

find in them no basis for reversal. Accordingly, we AFFIRM the judgment of the district court.

 FOR THE COURT: 

 CATHERINE O’HAGAN WOLFE, CLERK